67 related articles for article (PubMed ID: 9304221)
1. [Quality of the Early Cervical Cancer Detection Program in the State of Nuevo León].
Salinas-Martínez AM; Villarreal-Ríos E; Garza-Elizondo ME; Fraire-Gloria JM; López-Franco JJ; Barboza-Quintana O
Salud Publica Mex; 1997; 39(3):187-94. PubMed ID: 9304221
[TBL] [Abstract][Full Text] [Related]
2. Use of the Pap test by a population group in Buenos Aires.
Klimovsky E; Matos E
Bull Pan Am Health Organ; 1996 Dec; 30(4):313-21. PubMed ID: 9041742
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of cervical cancer screening program at a rural community of South Africa.
Hoque M; Hoque E; Kader SB
East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
[TBL] [Abstract][Full Text] [Related]
4. Cervical cancer screening in a rural population of Zimbabwe.
Thistle PJ; Chirenje ZM
Cent Afr J Med; 1997 Sep; 43(9):246-51. PubMed ID: 9509642
[TBL] [Abstract][Full Text] [Related]
5. Cervical cancer screening program of Paraná: cost-effective model in a developing country.
Bleggi Torres LF; Werner B; Totsugui J; Collaço LM; Araújo SR; Huçulak M; Boza EJ; Fischer RM; De Laat L; Sobbania LC; Raggio A
Diagn Cytopathol; 2003 Jul; 29(1):49-54. PubMed ID: 12827718
[TBL] [Abstract][Full Text] [Related]
6. The effect of the quality of Papanicolaou smears on the detection of cytologic abnormalities.
Mintzer M; Curtis P; Resnick JC; Morrell D
Cancer; 1999 Jun; 87(3):113-7. PubMed ID: 10385441
[TBL] [Abstract][Full Text] [Related]
7. Report from the CDC. Pap test intervals used by physicians serving low-income women through the National Breast and Cervical Cancer Early Detection Program.
Cooper CP; Saraiya M; McLean TA; Hannan J; Liesmann JM; Rose SW; Lawson HW
J Womens Health (Larchmt); 2005 Oct; 14(8):670-8. PubMed ID: 16232098
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with non-use of Pap test. A population survey.
Hernández-Hernández DM; García-Elizondo MR; Ornelas-Bernál L; Hernández-Alemán F; González-Lira G; Martínez-García MC
Arch Med Res; 1998; 29(3):263-70. PubMed ID: 9775462
[TBL] [Abstract][Full Text] [Related]
9. Pap smear screening among urban Southwestern American Indian women.
Risendal B; DeZapien J; Fowler B; Papenfuss M; Giuliano A
Prev Med; 1999 Dec; 29(6 Pt 1):510-8. PubMed ID: 10600432
[TBL] [Abstract][Full Text] [Related]
10. Adjunctive high-risk human papillomavirus DNA testing is a useful option for disease risk assessment in patients with negative Papanicolaou tests without an endocervical/transformation zone sample.
Zhao C; Austin RM
Cancer; 2008 Aug; 114(4):242-8. PubMed ID: 18484643
[TBL] [Abstract][Full Text] [Related]
11. Quality differences between rural and urban primary care: the case of a cervical cancer screening programme.
Salinas AM; Villarreal E; Garza ME; Fraire JM; Lopez JJ; Nuñez GM
Int J Qual Health Care; 1998 Jun; 10(3):235-40. PubMed ID: 9661062
[TBL] [Abstract][Full Text] [Related]
12. Augmentation of Pap smear screening of high risk aboriginal women. Use of a computerised process tool within the Broome Aboriginal Medical Service.
Couzos S; Wronski I; Murray R; Cox H
Aust Fam Physician; 1998 Apr; 27(4):269-74. PubMed ID: 9581335
[TBL] [Abstract][Full Text] [Related]
13. Why women still die from cervical cancer.
Masood S
J Fla Med Assoc; 1997; 84(6):379-83. PubMed ID: 9379163
[TBL] [Abstract][Full Text] [Related]
14. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
[TBL] [Abstract][Full Text] [Related]
15. Educational level and cervical cancer screening programs in a Venezuelan urban area.
Núñez-Troconis J; Velásquez J; Mindiola R; Munroe D
Invest Clin; 2008 Sep; 49(3):331-9. PubMed ID: 18846774
[TBL] [Abstract][Full Text] [Related]
16. Risk of invasive cervical cancer after Pap smears: the protective effect of multiple negatives.
Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
J Med Screen; 2005; 12(1):7-11. PubMed ID: 15814014
[TBL] [Abstract][Full Text] [Related]
17. [Cost-benefit analysis of the Program for Early Screening of Cervico-uterine Cancer].
Hernández-Peña P; Lazcano-Ponce EC; Alonso-de Ruiz P; Cruz-Valdez A; Meneses-González F; Hernández-Avila M
Salud Publica Mex; 1997; 39(4):379-87. PubMed ID: 9381251
[TBL] [Abstract][Full Text] [Related]
18. New tests for cervical cancer screening.
Nuovo J; Melnikow J; Howell LP
Am Fam Physician; 2001 Sep; 64(5):780-6. PubMed ID: 11563569
[TBL] [Abstract][Full Text] [Related]
19. Decreasing cervical cancer mortality in Mexico: effect of Papanicolaou coverage, birthrate, and the importance of diagnostic validity of cytology.
Lazcano-Ponce E; Palacio-Mejia LS; Allen-Leigh B; Yunes-Diaz E; Alonso P; Schiavon R; Hernandez-Avila M
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2808-17. PubMed ID: 18843027
[TBL] [Abstract][Full Text] [Related]
20. Knowledge and awareness of cervical cancer and screening among Malaysian women who have never had a Pap smear: a qualitative study.
Wong LP; Wong YL; Low WY; Khoo EM; Shuib R
Singapore Med J; 2009 Jan; 50(1):49-53. PubMed ID: 19224084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
